デフォルト表紙
市場調査レポート
商品コード
1427933

眼科ドラッグデリバリーの世界市場レポート 2024

Ocular Drug Delivery Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
眼科ドラッグデリバリーの世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

眼科ドラッグデリバリーの市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には7.6%の年間複合成長率(CAGR)で249億8,000万米ドルに成長すると予想されます。予測期間で予想される成長は、加齢に伴う眼疾患の発生率の増加、眼科分野における個別化医療への注目の高まり、眼科調査への投資の増加、長期の薬剤発売に対する需要の増加など、いくつかの要因に関連している可能性があります。目の健康を改善することを目的としたソリューションと世界の取り組み。予測期間中に予想される注目すべき動向には、スマートドラッグデリバリーデバイスの統合、眼科薬製剤における個別化医療の採用、局所眼科治療の開発、業界を超えたイノベーションを促進するコラボレーションが含まれます。これらの動向は総合的に、眼科ドラッグデリバリー市場の予想される拡大に貢献します。

眼科ドラッグデリバリー市場の予想される成長は、眼疾患の有病率の増加によって促進されると予想されます。眼疾患には、目、視力、または周囲の目の構造に影響を与える広範囲の症状が含まれます。 眼科ドラッグデリバリーは、標的部位に薬剤を直接送達し、治療効果を最適化し、全身性の副作用を最小限に抑え、さまざまな眼疾患に対処することにより、極めて重要な役割を果たします。たとえば、世界保健機関による2023年 3月の世界の推計では、世界中で22億人が近視または遠視の障害を経験すると予想されています。白内障(9,400万件)と未矯正の屈折問題(8,840万件)が、視覚障害の主な原因として際立っています。さらに、緑内障(770万件)、角膜混濁(420万件)、糖尿病網膜症(390万件)、トラコーマ(200万件)などの疾患も視力喪失に大きく寄与しています。したがって、眼疾患の有病率の増加は、眼科ドラッグデリバリー市場の成長の主要な推進力です。

眼科ドラッグデリバリー市場の成長は、高齢者人口の拡大によって促進されると予想されます。高齢者人口は通常65歳以上の個人として定義され、加齢黄斑変性症、緑内障、白内障などの加齢に伴う眼疾患の発生率が高くなります。 眼科ドラッグデリバリーの進歩により、高齢者のこれらの症状に対処するための有望なソリューションが提供されます。 2022年 10月の時点で、世界保健機関は、2030年までに世界中の6人に1人が60歳以上となり、その数は2020年の10億人に比べて14億人になると報告しています。60歳以上の人の数は2倍になると予測されています2050年までに21億人に増加し、80歳以上の人口は現在より4億2,600万人増加します。したがって、高齢者人口の増加は、眼科ドラッグデリバリー市場の成長にとって重要な原動力となります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界の眼科ドラッグデリバリー市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 植込み型眼科ドラッグデリバリーシステム
  • 粒子状ドラッグデリバリーシステム
  • ナノ粒子ドラッグデリバリーシステム
  • その他の技術
  • 世界の眼科ドラッグデリバリー市場、製剤別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • リポソームとナノ粒子
  • ソリューション
  • 乳剤
  • サスペンション
  • 軟膏
  • 世界の眼科ドラッグデリバリー市場、疾患別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 緑内障
  • 糖尿病性網膜症
  • ドライアイ症候群
  • 黄斑変性症
  • 白内障
  • 糖尿病性黄斑浮腫
  • その他の病気
  • 世界の眼科ドラッグデリバリー市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 眼科クリニック
  • 外来手術センター

第7章 地域および国の分析

  • 世界の眼科ドラッグデリバリー市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の眼科ドラッグデリバリー市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 眼科ドラッグデリバリー市場の競合情勢
  • 眼科ドラッグデリバリー市場の企業プロファイル
    • Pfizer Inc.
    • Roche Holding AG
    • AbbVie Inc.
    • Novartis AG
    • Allergan Inc.

第31章 その他の大手および革新的な企業

  • Regeneron Pharmaceuticals Inc.
  • Bausch Health Companies Inc.
  • Genentech Inc.
  • Santen Pharmaceutical Co. Ltd.
  • Akorn Inc.
  • Valeant Pharmaceuticals International Inc.
  • Aerie Pharmaceuticals Inc.
  • Alimera Sciences Inc.
  • Ocular Therapeutix Inc.
  • Ophthotech Corporation
  • Acucela Inc.
  • Graybug Vision Inc.
  • Amakem NV
  • Kala Pharmaceuticals Inc.
  • Icon Bioscience Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13777

Ocular drug delivery involves the targeted administration of medications or therapeutic agents to the eye, addressing specific conditions in various ocular tissues such as the cornea, conjunctiva, retina, or intraocular structures.

The key technology types in ocular drug delivery include implantable ocular drug delivery systems, particulate drug delivery systems, nano-particle drug delivery systems, and others. Implantable ocular drug delivery systems are designed for controlled drug release and are constructed from polymers that either degrade over time or remain intact. They come in diverse formulations, including liposomes, nanoparticles, solutions, emulsions, suspensions, and ointments. These systems find application in treating a range of eye conditions such as glaucoma, diabetic retinopathy, dry eye syndrome, macular degeneration, cataracts, diabetic macular edema, among others. Various end-users, including hospitals, ophthalmic clinics, and ambulatory surgical centers, utilize these delivery systems for administering ocular drugs effectively.

The ocular drug delivery market research report is one of a series of new reports from The Business Research Company that provides ocular drug delivery market statistics, including ocular drug delivery industry global market size, regional shares, competitors with an ocular drug delivery market share, detailed ocular drug delivery market segments, market trends and opportunities, and any further data you may need to thrive in the ocular drug delivery industry. This ocular drug delivery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The ocular drug delivery market size has grown strongly in recent years. It will grow from $17.39 billion in 2023 to $18.64 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth observed during the historic period can be ascribed to several factors, including an increase in ocular diseases, trends in an aging population, advancements in pharmaceutical formulations, clinical progress in ophthalmology, and the prevalence of eye conditions related to diabetes. These factors collectively contributed to the expansion of the ocular drug delivery market during that period.

The ocular drug delivery market size is expected to see strong growth in the next few years. It will grow to $24.98 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%. The anticipated growth in the forecast period can be linked to several factors, including the increasing incidence of age-related eye diseases, a heightened focus on personalized medicine within the field of ophthalmology, augmented investment in ophthalmic research, a growing demand for prolonged drug release solutions, and global initiatives aimed at improving eye health. Noteworthy trends expected in the forecast period encompass the integration of smart drug delivery devices, the adoption of personalized medicine in ocular drug formulations, the development of topical ophthalmic therapies, and collaborations fostering cross-industry innovations. These trends collectively contribute to the projected expansion of the ocular drug delivery market.

The anticipated growth in the ocular drug delivery market is expected to be propelled by the increasing prevalence of eye disorders. Eye disorders encompass a broad spectrum of conditions affecting the eyes, vision, or surrounding eye structures. Ocular drug delivery plays a pivotal role by delivering medications directly to the targeted site, optimizing therapeutic efficacy, minimizing systemic adverse effects, and addressing various eye disorders. For example, global estimates from the World Health Organization in March 2023 indicate that 2.2 billion people worldwide will experience near- or far-sighted impairment. Cataracts (94 million cases) and uncorrected refractive problems (88.4 million cases) stand out as the primary causes of visual impairment. Additionally, conditions such as glaucoma (7.7 million cases), corneal opacities (4.2 million cases), diabetic retinopathy (3.9 million cases), and trachoma (2 million cases) contribute significantly to vision loss. The increasing prevalence of eye disorders is thus a key driver for the growth of the ocular drug delivery market.

The growth of the ocular drug delivery market is anticipated to be fueled by the expanding geriatric population. The geriatric population, typically defined as individuals aged 65 and older, experiences a higher incidence of age-related eye diseases such as age-related macular degeneration, glaucoma, and cataracts. Advances in ocular drug delivery offer promising solutions for addressing these conditions in the elderly. As of October 2022, the World Health Organization reports that by 2030, 1 in 6 people worldwide will be aged 60 years or older, totaling 1.4 billion individuals compared to 1 billion in 2020. The number of individuals aged 60 and older is projected to double to 2.1 billion by 2050, with an additional 426 million people aged 80 or older compared to the present. The growing geriatric population is, therefore, a significant driver for the growth of the ocular drug delivery market.

Product innovation stands out as a prominent trend gaining traction in the ocular drug delivery market, with companies making significant efforts to introduce novel products and technologies to maintain their competitive edge. An example of this trend is evident in the initiatives of Alcon AG, a Swiss pharmaceutical and medical device company specializing in eye care products. In March 2023, Alcon launched TOTAL30 for astigmatism and SYSTANE HYDRATION for dry eye and ocular health. TOTAL30, the first Toric lens of its kind, combines Water Gradient and Celligent Technology to mimic the ocular surface's structure, providing superior performance in comfort, stability, and visual acuity. SYSTANE HYDRATION PF, an ocular health eye drop, employs HydroBoost technology to restore moisture, prevent irritation, and offer relief from dry eye symptoms.

Major players in the ocular drug delivery market are particularly focused on innovative solutions, including ophthalmic solutions targeting the signs and symptoms of dry eye disease (DED). An ophthalmic solution is a liquid medication applied directly to the eye for treating or preventing various eye conditions. For instance, Bausch + Lomb, a Canada-based pharmaceutical company specializing in ophthalmic products, launched Miebo, a perfluorohexyloctane ophthalmic solution, in the United States in September 2023. This prescription eye drop, administered four times a day, is water-, preservative-, and steroid-free, designed to reduce tear evaporation at the ocular surface and alleviate the signs and symptoms of dry eye disease.

In June 2022, Novartis AG, a Switzerland-based provider of innovative science and digital technologies for medical treatments, made a strategic move by acquiring Kedalion Therapeutics Inc. and its innovative ocular delivery platform for an undisclosed amount. This acquisition is expected to enhance Novartis's ophthalmic portfolio, allowing the company to deliver customer- and patient-centric advancements in ocular treatments. Novartis's commitment to reimagining medicine and improving medication delivery and patient experience is underscored by this acquisition. Kedalion Therapeutics Inc., the acquired entity, is a US-based developer and commercializer of transformative topical ophthalmic therapies.

Major companies operating in the ocular drug delivery market report are Pfizer Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Allergan Inc., Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Genentech Inc., Santen Pharmaceutical Co. Ltd., Akorn Inc., Valeant Pharmaceuticals International Inc., Aerie Pharmaceuticals Inc., Alimera Sciences Inc., Ocular Therapeutix Inc., Ophthotech Corporation, Acucela Inc., Graybug Vision Inc., Amakem NV, Kala Pharmaceuticals Inc., Icon Bioscience Inc., Clearside Biomedical Inc., Aerpio Therapeutics Inc., Senju Pharmaceutical Co. Ltd., Shire PLC, Spark Therapeutics Inc., Sucampo Pharmaceuticals Inc., Carl Zeiss Meditec AG, EyeGate Pharmaceuticals Inc.

North America was the largest region in the ocular drug delivery market in 2023. The regions covered in the ocular drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ocular drug delivery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ocular drug delivery market includes revenues earned by entities such as eye drops, eye gels, eye powders, and ocular injections. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ocular Drug Delivery Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ocular drug delivery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ocular drug delivery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ocular drug delivery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Technology: Implantable Ocular Drug Delivery Systems; Particulate Drug Delivery Systems; Nano-Particle Drug Delivery System; Other Technologies
  • 2) By Formulation: Liposomes And Nanoparticles; Solution; Emulsion; Suspension; Ointment
  • 3) By Disease: Glaucoma; Diabetic Retinopathy; Dry Eye Syndrome; Macular Degeneration; Cataract; Diabetic Macular Edema; Other Diseases
  • 4) By End User: Hospitals; Ophthalmic Clinics; Ambulatory Surgical Centers
  • Companies Mentioned: Pfizer Inc.; Roche Holding AG; AbbVie Inc.; Novartis AG; Allergan Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ocular Drug Delivery Market Characteristics

3. Ocular Drug Delivery Market Trends And Strategies

4. Ocular Drug Delivery Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Ocular Drug Delivery Market Size and Growth

  • 5.1. Global Ocular Drug Delivery Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Ocular Drug Delivery Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Ocular Drug Delivery Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Ocular Drug Delivery Market Segmentation

  • 6.1. Global Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Implantable Ocular Drug Delivery Systems
  • Particulate Drug Delivery Systems
  • Nano-Particle Drug Delivery System
  • Other Technologies
  • 6.2. Global Ocular Drug Delivery Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Liposomes And Nanoparticles
  • Solution
  • Emulsion
  • Suspension
  • Ointment
  • 6.3. Global Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Glaucoma
  • Diabetic Retinopathy
  • Dry Eye Syndrome
  • Macular Degeneration
  • Cataract
  • Diabetic Macular Edema
  • Other Diseases
  • 6.4. Global Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers

7. Ocular Drug Delivery Market Regional And Country Analysis

  • 7.1. Global Ocular Drug Delivery Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Ocular Drug Delivery Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Ocular Drug Delivery Market

  • 8.1. Asia-Pacific Ocular Drug Delivery Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Ocular Drug Delivery Market

  • 9.1. China Ocular Drug Delivery Market Overview
  • 9.2. China Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Ocular Drug Delivery Market

  • 10.1. India Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Ocular Drug Delivery Market

  • 11.1. Japan Ocular Drug Delivery Market Overview
  • 11.2. Japan Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Ocular Drug Delivery Market

  • 12.1. Australia Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Ocular Drug Delivery Market

  • 13.1. Indonesia Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Ocular Drug Delivery Market

  • 14.1. South Korea Ocular Drug Delivery Market Overview
  • 14.2. South Korea Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Ocular Drug Delivery Market

  • 15.1. Western Europe Ocular Drug Delivery Market Overview
  • 15.2. Western Europe Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Ocular Drug Delivery Market

  • 16.1. UK Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Ocular Drug Delivery Market

  • 17.1. Germany Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Ocular Drug Delivery Market

  • 18.1. France Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Ocular Drug Delivery Market

  • 19.1. Italy Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Ocular Drug Delivery Market

  • 20.1. Spain Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Ocular Drug Delivery Market

  • 21.1. Eastern Europe Ocular Drug Delivery Market Overview
  • 21.2. Eastern Europe Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Ocular Drug Delivery Market

  • 22.1. Russia Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Ocular Drug Delivery Market

  • 23.1. North America Ocular Drug Delivery Market Overview
  • 23.2. North America Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Ocular Drug Delivery Market

  • 24.1. USA Ocular Drug Delivery Market Overview
  • 24.2. USA Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Ocular Drug Delivery Market

  • 25.1. Canada Ocular Drug Delivery Market Overview
  • 25.2. Canada Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Ocular Drug Delivery Market

  • 26.1. South America Ocular Drug Delivery Market Overview
  • 26.2. South America Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Ocular Drug Delivery Market

  • 27.1. Brazil Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Ocular Drug Delivery Market

  • 28.1. Middle East Ocular Drug Delivery Market Overview
  • 28.2. Middle East Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Ocular Drug Delivery Market

  • 29.1. Africa Ocular Drug Delivery Market Overview
  • 29.2. Africa Ocular Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Ocular Drug Delivery Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Ocular Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Ocular Drug Delivery Market Competitive Landscape And Company Profiles

  • 30.1. Ocular Drug Delivery Market Competitive Landscape
  • 30.2. Ocular Drug Delivery Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Roche Holding AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. AbbVie Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Novartis AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Allergan Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Ocular Drug Delivery Market Other Major And Innovative Companies

  • 31.1. Regeneron Pharmaceuticals Inc.
  • 31.2. Bausch Health Companies Inc.
  • 31.3. Genentech Inc.
  • 31.4. Santen Pharmaceutical Co. Ltd.
  • 31.5. Akorn Inc.
  • 31.6. Valeant Pharmaceuticals International Inc.
  • 31.7. Aerie Pharmaceuticals Inc.
  • 31.8. Alimera Sciences Inc.
  • 31.9. Ocular Therapeutix Inc.
  • 31.10. Ophthotech Corporation
  • 31.11. Acucela Inc.
  • 31.12. Graybug Vision Inc.
  • 31.13. Amakem NV
  • 31.14. Kala Pharmaceuticals Inc.
  • 31.15. Icon Bioscience Inc.

32. Global Ocular Drug Delivery Market Competitive Benchmarking

33. Global Ocular Drug Delivery Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Ocular Drug Delivery Market

35. Ocular Drug Delivery Market Future Outlook and Potential Analysis

  • 35.1 Ocular Drug Delivery Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Ocular Drug Delivery Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Ocular Drug Delivery Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer